Skip to main content

Table 5 Multivariate sensitivity analysis considering different scenarios in a time horizon of 4 years and according to life expectancy

From: Ablation by three-dimensional electroanatomical mapping versus anti-arrhythmic drug therapy: a cost-utility analysis in the treatment of idiopathic ventricular arrhythmias

Scenario

 

4-year time horizon

Time horizon according to life expectancy

Input:

Optimistic

Most likely

Pessimistic

Optimistic

Most likely

Pessimistic

3D Ablation (USD)

6,047.99

6,652.79

7559.99

6,047.99

6,652.79

7559.99

External consultation (USD)

16.49

17.31

18.14

16.49

17.31

18.14

Antiarrhythmics

0%

10%

25%

0%

10%

25%

Transfers

0%

5%

10%

0%

5%

10%

Cardiological exams

0%

10%

25%

0%

10%

25%

Output:

      

ACUR − 3D ablation.

2,187

2,397

2,710

230.94

252.61

284.7

ACUR - antiarrhythmics

716

767

835

646.01

698.59

773.11

ACUR difference

1,471

1,630

1,876

415.08

445.98

488.41

  1. ACUR: Average Cost-Utility Ratio